Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, and Hepatitis Viruses Studies and Epidemiology.
AASLD IDSA Practice Guideline on treatment of chronic hepatitis B
Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of age
National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern
Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trial
Striving for universal birth dose hepatitis B vaccination in Canada: data from Ontario make a compelling case
Pharmacist‐Led Hepatitis C Diagnosis and Rapid Management—In Community ( <scp>PHARM</scp> ‐C): Results From a Phase <scp>IV</scp> Nonblinded Randomised Controlled Trial
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy
Predictors of hepatic flares after nucleos(t)ide analogue cessation – Results of a global cohort study (RETRACT-B study)
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic review
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries
Maternal neighbourhood‐level social determinants of health and their association with paediatric hepatitis C screening among children exposed to hepatitis C in pregnancy
Factors associated with knowledge and awareness of Hepatitis B in individuals of Chinese descent: Results from a mass point of care testing and outreach campaign in Toronto, Canada
Differential Gene Expression in the Upper Respiratory Tract following Acute COVID-19 Infection in Ambulatory Patients That Develop Long COVID
Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario
An evolutionary concept analysis: stigma among women living with hepatitis C
Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada
Equitable access to direct-acting antivirals: Canada's path to a hepatitis C-free tomorrow
Early Treatment with Pegylated Interferon Lambda for Covid-19
New Perspectives on Development of Curative Strategies for Chronic Hepatitis B
Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients
Pathway to global elimination of hepatitis B: HBV cure is just the first step
Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America
Province-to-province variability in hepatitis C testing, care, and treatment across Canada
Increasing linkage to hepatitis C care following trauma‐informed rehabilitation: An education and quality improvement project among women
Joint statement in support of hepatitis C human challenge studies
Host Expression Profiling From Diagnostic Coronavirus Disease 2019 Swabs Associates Upper Respiratory Tract Immune Responses With Radiologic Lung Pathology and Clinical Severity
Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries
Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B